Home › Funds › Convergence Investment Partners, LLC › JNJ

Convergence Investment Partners, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Convergence Investment Partners, LLC reported holding 30,696 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$8.1M, representing 0.60% of its reported portfolio and ranking #42 among its reported holdings. Convergence Investment Partners, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)30.70K sh
Reported value held$8.13M
Portfolio Weight0.60%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Convergence Investment Partners, LLC's JNJ position evolved

Convergence Investment Partners, LLC first disclosed a stake in JNJ in Q3 2023 at 6,679 shares (US$1.0M). The position peaked in Q3 2026 at 30,696 shares, worth US$8.1M. Across 13 filings, Convergence Investment Partners, LLC increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 30,696 shares valued at US$8.1M — an increase of 725 shares quarter over quarter.. Notable position changes include a 54% increase in Q2 2024 (shares rose 11% over the following quarter), a 33% increase in Q1 2026 (shares rose 4% over the following quarter), a 84% increase in Q2 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 6.68K $1.04M New
Q4 2023 6.71K $1.05M Add
Q1 2024 8.94K $1.41M Add
Q2 2024 13.81K $2.02M Add
Q3 2024 14.29K $2.32M Add
Q4 2024 16.19K $2.34M Add
Q1 2025 12.81K $2.12M Reduce
Q2 2025 12.13K $1.85M Reduce
Q3 2025 12.47K $2.31M Add
Q4 2025 12.22K $2.53M Reduce
Q1 2026 16.30K $3.98M Add
Q2 2026 29.97K $7.61M Add
Q3 2026 30.70K $8.13M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Convergence Investment Partners, LLC held JNJ?

Convergence Investment Partners, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Convergence Investment Partners, LLC's current position in JNJ?

As of Q3 2026, Convergence Investment Partners, LLC holds 30.70K shares of JNJ (JOHNSON & JOHNSON), valued at $8.13M, representing 0.60% of its reported portfolio and ranking #42.

Has Convergence Investment Partners, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Convergence Investment Partners, LLC increased its position in JNJ. The position peaked in Q3 2026 at 30.70K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.